PDCD1 and neoplasm: Ablation of the PD-L1-PD-1 interaction by neutralizing antibodies could restore CTL-mediated killing of tumor cells, suggesting that PD-L1-PD-1 interaction forms a barrier between tumor cells and CTL 53.